Biomarker Menu

document-download

Download this assay page in pdf format.

Download

TGF ß-1 (Transforming Growth Factor ß-1) - ELISA

Analyte: Transforming Growth Factor ß-1

Specimen Type: Platlet Poor EDTA Plasma; Please contact PBI for collection instructions

Optimum Volume: 0.5 mL

Stability:

2-8°C -20°C -70°C
1 day N.A. 9 years

Reporting units: pg/mL

Method: ELISA

Biological or Clinical Significance:

Transforming growth factor (TGF), a ‘factor’ that promoted the transformation of cultured fibroblasts into a tumor-like phenotype, was subsequently found to be more of a tumor suppressor than tumor promoter and to be a mixture of two proteins, TGF-α and TGF-β. These molecules are members of a superfamily that includes TGF-β 1 through 5, bone morphogenic proteins, activins and inhibins. Human TGF-β 1 is a 25 kDa, disulfide-linked, non-glycosylated homodimer.

TGF-β 1 is cleaved from the C-terminus of a disulfide-linked dimer of pro-TGF-β 1 by a subtilisin-like pro-protein convertase protease. It is normally secreted as an inactive, or latent, complex.

Two different receptor proteins are involved in TGF-β 1 signaling.TGF-β 1 is synthesized, with only a few exceptions, by virtually all cells, and TGF receptors are expressed by all cells.

There are three fundamental activities: TGF-β 1 modulates cell proliferation, generally as a suppressor; TGF-β1 enhances the deposition of extracellular matrix through promotion of synthesis and inhibition of degradation; TGF-β 1 is immunosuppressive through a variety of mechanisms. The specific action of TGF-β on a particular cell depends on the exact circumstances of that cell’s environment.

Principle of Test Method:

The TGF-B1 assay is a solid-phase ELISA that employs the quantitative sandwich enzyme immunoassay principle.

Downloadable, Printable Biomarker Menus

Alphabetical Listing

Download PDF

Biomarker Category

Download PDF